In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate

This publication has 35 references indexed in Scilit:

• Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetate
  Gynecologic Oncology, 1985
• Tamoxifen and endometrial carcinoma: Alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia
  American Journal of Obstetrics and Gynecology, 1984
• Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma
  Gynecologic Oncology, 1981
• Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications
  American Journal of Obstetrics and Gynecology, 1981
• Endometrial Carcinoma Insensitive to Progestin and Cytotoxic Chemotherapy May Respond to Tamoxifen
  Acta Obstetricia et Gynecologica Scandinavica, 1981
• Clinical Correlates of Estrogen- and Progesterone-Binding Proteins in Human Endometrial Adenocarcinoma
  Obstetrics & Gynecology, 1980
• Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration
  International Journal of Cancer, 1979
• Treatment of Advanced Endometrial Carcinoma with Tamoxifen
  New England Journal of Medicine, 1979
• Regulation of cytosol and nuclear progesterone receptors in rabbit uterus by estrogen, antiestrogen and progesterone administration
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1979
• Gestagens and endometrial carcinoma
  Gynecologic Oncology, 1976